Analysis reveals youth using CIQ had greater time in range than those using Omnipod 5, suggesting significant system differences.
OBJECTIVE To assess differences in time in range (TIR) between automated insulin delivery (AID) systems in youth with low bolus frequency. RESEARCH DESIGN AND METHODS Youth using Omnipod 5 (OP5) or Tandem Control-IQ (CIQ) averaging ≤3.0 boluses/day over 90 days were included. Propensity score matching accounted for between-group differences. A multiple linear regression model assessed for differences in TIR by system. RESULTS A total of 202 youth had low bolus frequency (n = 75 of 290 using CIQ, n = 127 of 535 using OP5; P = 0.5). Propensity score matching paired 98 youth for analyses and eliminated between-group differences, excluding time in AID, which remained higher for CIQ users (80.0% vs. 64.0%; P = 0.01). There was no between-group difference in user-initiated boluses (2.2 boluses/day). Adjusted TIR was 8.0% higher in CIQ users (54.9% vs. 46.9%; P = 0.002). CONCLUSIONS Among AID users receiving ≤3.0 boluses/day, CIQ use was associated with greater TIR, likely due to increased time in AID and AID-initiated boluses.
No takes yet. Share an insight, caveat, or question.
Chatty et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: